MedPath

ILUMYA

ILUMYA

Approved
DIN Number

02516098

Drug Class

Human

Market Date

Aug 4, 2021

Company
HC

SUN PHARMACEUTICAL INDUSTRIES LIMITED

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02516098
AIG Number0162907001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L04AC17 TILDRAKIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification84:06.28
Health Canada Classification

ACTIVE INGREDIENTS (1)

TILDRAKIZUMABActive
Strength: 100 MG / ML
Monograph: TILDRAKIZUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.